Business
NovelStem Increases NewStem Ownership to 33% as NewStem Preps for 1H'21 FDA Filing for Approval of Stem-Cell Based Anti-Cancer Drug Resistance Diagnostic; Initiates Process to Be Publicly Reporting...
NovelStem Increases NewStem Ownership to 33% as NewStem Preps for 1H'21 FDA Filing for Approval of Stem-Cell Based Anti-Cancer Drug Resistance Diagnostic; Initiates Process to Be Publicly Reporting....
About this update from Novelstem International Corp.
[{"type":"text","content":"","length":30,"tagName":"div"}]